Activating Compound | Comment | Organism | Structure |
---|---|---|---|
additional information | in vivo, administration of mesenchymal stromal cells to mice subjected to middle cerebral artery occlusion significantly increases activation of tPA and downregulates PAI-1 levels in the ischemic boundary zone compared with control PBS treated mice, concurrently with increases of myelinated axons and synaptophysin | Mus musculus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
plasminogen activator inhibitor 1 | PAI-1, specific endogenous inhibitor, in vivo, administration of mesenchymal stromal cells to mice subjected to middle cerebral artery occlusion significantly increases activation of tPA and downregulates PAI-1 levels in the ischemic boundary zone compared with control PBS treated mice, concurrently with increases of myelinated axons and synaptophysin | Mus musculus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mus musculus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
astrocyte | - |
Mus musculus | - |
neuron | - |
Mus musculus | - |
Synonyms | Comment | Organism |
---|---|---|
Tissue plasminogen activator | - |
Mus musculus |
tPA | - |
Mus musculus |
General Information | Comment | Organism |
---|---|---|
physiological function | tissue plasminogen activator, tPA, and its inhibitors contribute to neurite outgrowth in the central nervous system after treatment of stroke with multipotent mesenchymal stromal cells. Critical role of tPA in facilitating neurite outgrowth. Bone marrow stromal cells modulate endogenous tPA level and activity in the ischemic boundary zone, IBZ | Mus musculus |